Acadia Healthcar SEC Filings

Acadia Healthcare (ACHC) reported an insider equity award for its Chief Financial Officer, Todd S. Young. On 10/27/2025, he acquired 48,445 shares of common stock at $0.00 per share. According to the filing, these shares will vest over three years in equal annual installments beginning 10/27/2026. Following this transaction, Young beneficially owned 48,445 shares, held directly.

Acadia Healthcare (ACHC): A Form 3 was filed for Chief Financial Officer Todd S. Young, reporting his initial beneficial ownership with the issuer. The filing states that no securities are beneficially owned.

The event date is 10/27/2025, and the Form 3 was signed by Brian Farley as attorney-in-fact on 10/28/2025 pursuant to an Exhibit 24 power of attorney.

Acadia Healthcare Company, Inc. disclosed an employment agreement for Todd Young dated October 7, 2025 that sets compensation and relocation terms for his role. The package includes a one-time $460,000 cash award payable by March 31, 2026 if he remains employed through that date, a one-time grant of time-based restricted stock units with a grant-date fair value of $1,200,000 that vest ratably over three years, and a minimum annual equity award for fiscal 2026 with grant-date fair value of at least $2,900,000. The agreement also provides eligibility for severance on certain terminations and reimbursement for reasonable relocation expenses to the greater Franklin, Tennessee area within 12 months of his start date.

The Vanguard Group reported owning 9,417,045 shares of Acadia Healthcare Company, Inc., representing 10.19% of the outstanding common stock as of 09/30/2025. Vanguard reports 0 shares of sole voting power, 598,737 shares of shared voting power, 8,718,595 shares of sole dispositive power, and 698,450 shares of shared dispositive power. The filing states these shares are held in the ordinary course of business and not for the purpose of changing or influencing control. The reporting address is 100 Vanguard Blvd., Malvern, PA, and the filing is signed by Ashley Grim, Head of Global Fund Administration, on 10/06/2025.

Wellington Management and related entities report beneficial ownership of 9,423,548 shares of Acadia Healthcare Company, Inc. common stock, representing 10.2% of the class as of the event date 09/30/2025. The filing is a Schedule 13G amendment listing four Wellington-related filers organized in Massachusetts and Delaware. The reported holdings show no sole voting or dispositive power and instead reflect shared voting power of 8,982,886 shares and shared dispositive power of 9,423,548 shares, indicating these securities are owned of record by Wellington clients and managed by its investment advisers. The filing names one client exceeding a 5% threshold: the Vanguard Health Care Fund. Signatures are provided by a Wellington regulatory analyst on 10/07/2025.

Insider sale reported: Nasser Khan, listed as Chief Operating Officer and reporting person for Acadia Healthcare Company, Inc. (ACHC), disposed of 973 shares of common stock on 09/30/2025 at a reported price of $24.54 per share. After the transaction he beneficially owned 55,023 shares in a direct ownership form. The Form 4 was signed by an attorney-in-fact on 10/01/2025.

Khrom-affiliated investors disclosed a meaningful 5.5% stake in Acadia Healthcare (ACHC), holding 5,037,448 shares directly through Khrom Investments and 5,044,376 shares when including Eric Khrom's direct holdings. The group acquired the shares in open-market purchases for an aggregate purchase price of approximately $132.89 million using working capital, and the shares are held in margin accounts. The filing states the investors believe ACHC is undervalued and that they have engaged, and intend to continue engaging, with the company’s management and board about strategic options to maximize shareholder value. The investors reserve the right to buy or sell additional securities, pursue derivative or hedging transactions, and potentially propose changes to operations, board composition, capital structure or other strategic actions.

Acadia Healthcare Company, Inc. is providing preliminary 2026 guidance and an interim operating update alongside a conference appearance. For 2026, the company expects total capital expenditures to decline by at least $300 million compared with its 2025 capital expenditure guidance of $600 to $650 million, indicating a materially lower investment spend next year. Acadia also expects to add 500 to 700 beds in 2026, including beds already under construction in 2025, highlighting ongoing capacity expansion.

For the third quarter of 2025, Acadia is disclosing a select interim operating metric, reporting same facility patient days growth to date of approximately 1.3%. The company notes that forward-looking statements, including these expectations, are subject to risks such as integration of expansions and acquisitions, changes in government and commercial reimbursement, the impact of the One Big Beautiful Bill Act on Medicaid financing and eligibility, labor and cost pressures, cybersecurity risks, and broader economic conditions.

Timothy Sides, Interim CFO of Acadia Healthcare (ACHC), reports direct beneficial ownership of 30,661 shares of common stock and ownership of stock options covering 4,825 underlying shares. The options include grants exercisable in 2022, 2023, and 2024 with exercise prices of $57.14, $53.40, and $80.87 and expirations in 2031, 2032, and 2033 respectively. Several equity awards have staggered vesting schedules that begin in 2026 and extend up to three years.